The 2014 OS

Join us at the 2014 Open Session in Cavtat

Research Group

2012 Open Session of the EuFMD Standing Technical Committee

Jerez, Spain

29-31 October 2012

Appliance of Science in the Progressive Control of Foot-and-Mouth Disease

Agenda

Appendixes 

Session I: Opening - Monday 29 October: Plenary hall

Frenkel's legacy: What is keeping us? P.DeLeeuw

Global surveillance: European neighbourhood and global FMD situation, J.Hammond

Session II: Focus on issues affecting FMD control in FMD free regions

Aligning waiting periods for vaccinate-to-live and vaccinate-to-die, D.Geale

A quantitative approach to determining waiting periods for FMD freedom, A.Cameron

Evaluation of the benefits and feasibility of a vaccination-to-live strategy in fmd free countries, D.Hadorn

FMD in wild boar and policy implications, K.Depner [Not available]  

FMD in wild boar: can the virus be maintained in wildlife? Experiences and consequences from Thrace, S.Khomenko 

Session III: Focus on issues affecting FMD control in FMD free regions

FMD lab bio-risk management: what have we learnt from application of the 2009 minimum standards, B.Haas

Economic evaluation of fmd management options: implications for science and policy, R.Bergevoet

Simple decision tools informed by model predictions when considering FMD emergency vaccination strategies, P.Willeberg

Session IV: Progressive Control Pathway for FMD (PCP-FMD): Results, Technical developments and Issues

Progressive Control Pathway (PCP) Stage 1-3 Results, Technical developments and issues, C.Bartels, N.DeHaan, M.Mclaws 

Socioeconomics: Enhanced FMD control through the integration of socio-economic approaches, C.Bartels, N.DeHaan, M.Mclaws

The role of the OIE in FMD prevention and control. How to translate science in standards and guidelines, how to develop tools and ensure their convergence, J.Domenech 

Session P1: - Monday 29 October- Parallel Session: Immunology and Vaccine Research

The cellular innate immune response during acute infection of cattle and swine with FMDV, W.Golde

Adaptive immune responses in the respiratory tract of FMD-vaccinated cattle after oronasal infection, M. Perez Filgueira

Characterization of opsonizing antibodies against FMD virus, A. Summerfield

Whole 140s FMDV particles are needed to elict specific cellular immunity in vivo and to stimulate recal responses in vitro, A.V.Capozzo [Not available] 

Intra-serotype chimeric FMD Vaccine Antigen elicit protection in cattle, F.Maree

Session P2: -Immunology and Vaccine Research

Production and evaluation of FMDV stabilised capsids as potent, rapidly deployable vaccines, B. Charleston

Development of a bovine enterovirus-based vector that expresses multi-epitopes of FMDV, J.H. Park

Development and evaluation of an adenovirus vector based intranasal FMDV capsid vaccine, A. Babu

Alternative FMD vaccine potency tests based on serology and antigen payload, T. Willems

Towards challenge-free FMD vaccine batch acceptance, R. Reeve

Relation between antibody response and protection in FMD vaccine depends on vaccine quality, A. Dekker

Cross-protection against current Asia1 field isolates is provided by a high potency Asia1 Shamir Vaccine, Y.Li

Testing the efficacy of 01 Manisa high potency vaccine against challenge with 0/Vietnam/2010 (0MYA98 tototype) in pigs, W.Vosloo

Antibody titres in fmd type A strains:comparison of methodologies to predict cross-protection, T.Tesfaalem

Session V: Tuesday 30 October- Plenary Session: FMD Epidemiology: Transmission, virus circulation, risk factor 

Local differences in circulation, what have we learnt from patterns of FMD persistence and spread, N.Knowles 

Limited transmission of fmdv from infected sheep to naive calves, C.Bravo de Rueda

Fmdv infection in vaccinated and non-vaccinated sheep: transmission to contact animals and diagnostic aspects, P.Eble'

Transmission of fmdv from infected buffalo (Bubalus bubalis) to vaccinated and naive buffalo and cattle, M.Madhanmohan

Within herd transmission and evaluation of performance of clinical and serological diagosis of fmd in vaccinated cattle, J.L. Gonzales [Not available] 

Session VI: FMD Epidemiology 2 

FMDV in the African buffalo (Syncerus caffer) in Kenya, S.Wekesa

Seroprevalence profile of fmd in wildlife populations of West and Central African Regions with special reference to syncerus caffer subspecies, A.DiNardo

Epidemiological patterns and risk factors for FMD exposure in traditional livestock keeping systems of Northern Tanzania, T.Lembo 

Retrospective serosurvey of FMD in free ranging domestic pigs and wild suids in Sub-Saharan African countries, M.Arias

Risks associated with unofficial livestock movements in the greater Mekong region, A.Cameron

Risk factors for fmd in beef cattle herds in Israel, E.Klement

Risk mapping of fmd disease prevalence in Central Asian countries, A.DiNardo

Session VII: FMD Epidemiology 3

Prevalence and risk factors for FMD-NSP antibodies in cow and buffalo calves and small ruminants in Egypt, C.Van Maanen

Determining the level of vaccine-induced versus field-virus induced antibodies in livestock in West Azerbaijan, Iran, C.Bartels

Spatio-temporal origin and transmission of the fmdv outbreaks in Burgas region (Bulgaria) in 2011, B.Valdazo

Molecular epidemiology of fmdv in the african buffaloes in Southern Africa, C.Kasanga [Not available] 

Session VIII: Vaccination programmes

Effectiveness of vaccination programmes, P.Fine

Fmd Asia1 vaccine effectivness in Turkey, T.Knight-Jones

An investigation of vaccine effectivness in two Cambodian villages facing an outbreak of fmd, A.Cameron

The field effectiveness of inactivated vaccine for prevention of fmd, E.Klement

Fmd: vaccine impact and Progressive Control in India, S.N.Singh

A high throughput liquid phase blocking elisa for quantitative estimation (...), G.K.Sharma[Not available] 

Session P3: - Tuesday 30 October- Parallel Session: Immunology and Vaccine Research

Antigenic cartography for analysis of antigenic variations in fmdv, B.Pattnaik [Not available]

Evidence of further neutralisation after removal of 5 neutralising antigenic sites in serotype 0, A.Asfor

Determining the epitope dominance on the capsid of a SAT2 fmdv by mutational analysis, P.A.Opperman

Development of a predictive model for VM for sertotype 0, M.Mahapatra

Session P4: FMD management 

Modelling into policy: How can an "Intelligent Customer"approach ensure appropriate use of evidence? F.Gauntlett

Scaling up from 1-to-1 animal transmission experiments to epidemiological (...), D. Schley

Epidemiological models of fmd in two different Austrian regions, J.Hiesel

Multi-criteria decision analysis for evaluating control options during fmd outbreaks, K.Mintiens

Meta-analysis on the efficacy of fmd emergency vaccination, T.Halasa

Evaluating vaccination for fmd control - an international study, M.G.Garner

Session P5: Complementary research

A new approach to the oldest disease developing an antiviral drug (...), N.Goris

The Pyrazinecarboxamide derivative t-1105 offers protection against 01Manisa(...), A.De Vleeschauwer

Session P6: FMD management 

Optimizing the control of FMD in Denmark by simulation. Comparison of different control strategies, A.Boklund

Modelling the spread of fmd in endemic regios, M. Tildelsey

Assessing and comparing control strategies for fmd in endemic countries (...), M.S.Salman [Not available]

Geographically-grounded, cost-benefit based control policies: built as equal circles (...), A.L.Rivas

Costs and benefits of fmds practises in commercial dairy farms in central Ethiopia, A.F.Beyi

Session IX: Wednesday  31 October- Plenary Session: Diagnostic Developments and Laboratory Networks

New ELISA's for fmd, E.Brocchi

FMD and SVD combined proficency test studies 2011, B.Armson

New roles for 'Auxiliary labs' in the diagnosis of fmd, B.Haas

Open fmd a resource for automatic and curated nomenclatures and tools (...), P.Claes

Development and evaluation of a realtime reverse transcription -loop-mediated isothermal (...), M.Madhanmohan [Not available]

Session X: Diagnostic Developments and Applications

Diagnostic performance of an immunochromatographic lateral-flow strip test using generic rapid assay (...), Z.Zhan

Development and evaluation of a one-step duplex real-time RT-PCR for diagnosis of fmd, K.Gorna

The development and evaluation of a SAT-adapted 3ABC Diva test for fmdv in the Southern African context, M.Chitray

Detection, isolation and typing of fmd from oral swab samples collected from Balochistan province of Pakistan, M.Assad Ullah

Session P7: GFRA meeting: an African perspective

GFRA: State of the alliance overview, F.Maree

Role of buffalo in the maintenance of fmdv, B.Charleston

Fmdv ecology: collaborative studies, L.Rodriguez

Development of a safe antigenic marker fmd vaccine platform, E.Rieder

Top priorities for research, D.Paton

GFRA workshop in 2013 and concluding remarks, F.Maree

Session P8: Fmd Monitoring and Surveillance: experience, methods and approaches

Estimating the incidence of fmd, M.Mclaws

Risk factors for transmission of fmd during an outbreak in Southern England in 2007, K.Sharpe

The use of oral fluids from pig herds for pre-clinical diagnosis and monitoring in an fmd emergency (...), Z.Zhang

Fmdv transboundary movements between Subsaharan Africa, North Africa and the Middle East, N.Knowles

Maximising efficiency with a surveillance strategy for fmd during an outbreak in a previously fmd-free country, K.Walker [Not available]